March 5, 2004 — The results of a substudy from the Rate Control Versus Electrical Cardioversion for Persistent Atrial Fibrillation (RACE) trial find that patients with persistent atrial fibrillation ...

CHICAGO, IL—A quality-improvement program from the Heart Rhythm Society was associated with improvements in care for patients early after they received a diagnosis of atrial fibrillation (AF), ...

Please provide your email address to receive an email when new articles are posted on . In patients with atrial fibrillation, compared with usual care, early rhythm control therapy reduced risk for ...

Sophia Antipolis, 27 March 2023: Patients with atrial fibrillation (AF) benefit from early rhythm control therapy. It reduces cardiovascular deaths, strokes, and other adverse outcomes by 20% compared ...

The US atrial fibrillation (AF) guideline has received its first full update in nearly a decade, providing a new staging system, an emphasis on early rhythm control, and upgraded recommendations for ...

Please provide your email address to receive an email when new articles are posted on . A quality improvement initiative raised the proportion of patients with atrial fibrillation who received an ...

A recent randomized trial in Czechia tested the premise that lifestyle modification and use of antiarrhythmic drugs was as effective as catheter ablation (CA) to treat atrial fibrillation (AF). The ...

Low concentrations of three selected biomarkers in the blood of patients with atrial fibrillation identify patients with a high chance of attaining sinus rhythm. This is the main result of this ...

Old concerns about the safety of rhythm control drugs for atrial fibrillation (Afib or AF) resurfaced in a contemporary large Korean population-based study. Afib patients prescribed antiarrhythmic ...

What changed?: The COMPASS initiative boosted early rhythm control use in AF from 28.8% to 32.8% within six months of diagnosis. Specialist access up: Referrals to electrophysiologists rose from 22.6% ...